Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis
- PMID: 16574727
- PMCID: PMC2077642
- DOI: 10.1136/jnnp.2005.086116
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis
Abstract
The intrathecal synthesis of IgM, determined at clinical onset in patients with multiple sclerosis, was found to correlate with the degree of disability (as evaluated by means of the Expanded Disability Status Scale) reached 15 years later (p<0.001). Moreover, a significant inverse correlation was observed between the value of the IgM index and time to the first relapse (p<0.001) and the initiation of the progressive phase of the disease (p = 0.01). The prognostic value of IgM in the CSF is confirmed in previous reports as well as by our study. If these findings are confirmed in patients with multiple sclerosis in a larger series, a helpful biological marker for selecting patients for immunomodulatory treatments will be available to neurologists.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.Clin Neurol Neurosurg. 2017 Sep;160:27-29. doi: 10.1016/j.clineuro.2017.05.026. Epub 2017 Jun 1. Clin Neurol Neurosurg. 2017. PMID: 28622533
-
Intrathecal immunoglobulin M synthesis in multiple sclerosis. Relationship with clinical and cerebrospinal fluid parameters.Brain. 1991 Feb;114 ( Pt 1A):181-95. Brain. 1991. PMID: 1998881
-
Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis.Mult Scler. 2011 Mar;17(3):327-34. doi: 10.1177/1352458510388543. Epub 2010 Dec 1. Mult Scler. 2011. PMID: 21123302
-
Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.Mult Scler. 2012 May;18(5):587-91. doi: 10.1177/1352458511424589. Epub 2011 Sep 30. Mult Scler. 2012. PMID: 21965422
-
Intrathecal IgM as a Prognostic Marker in Multiple Sclerosis.Mol Diagn Ther. 2020 Jun;24(3):263-277. doi: 10.1007/s40291-020-00455-w. Mol Diagn Ther. 2020. PMID: 32162206 Review.
Cited by
-
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis.Ann Neurol. 2021 Sep;90(3):477-489. doi: 10.1002/ana.26137. Epub 2021 Jun 22. Ann Neurol. 2021. PMID: 34057235 Free PMC article.
-
Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.Brain. 2024 Mar 1;147(3):839-848. doi: 10.1093/brain/awad424. Brain. 2024. PMID: 38123517 Free PMC article.
-
A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease.J Neurol. 2008 Jul;255(7):1023-31. doi: 10.1007/s00415-008-0827-5. Epub 2008 Jun 13. J Neurol. 2008. PMID: 18535872
-
The Cerebrospinal Fluid in Multiple Sclerosis.Front Immunol. 2019 Apr 12;10:726. doi: 10.3389/fimmu.2019.00726. eCollection 2019. Front Immunol. 2019. PMID: 31031747 Free PMC article. Review.
-
SUCCESSFUL TREATMENT OF ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM) BY PROMPT USAGE OF IMMUNOGLOBULINS - CASE REPORT AND REVIEW OF THE LITERATURE.Acta Clin Croat. 2019 Mar;58(1):173-179. doi: 10.20471/acc.2019.58.01.22. Acta Clin Croat. 2019. PMID: 31363340 Free PMC article.
References
-
- Sharief M K, Thompson E J. Intrathecal immunoglobulin M synthesis in multiple sclerosis. Brain 1991114181–195. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical